These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27266824)

  • 21. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
    Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Zaromitidou M; Kioufis S; Maniatis K; Dilaveris P; Miliou A; Michalea S; Papavassiliou AG; Stefanadis C
    Atherosclerosis; 2013 Apr; 227(2):367-72. PubMed ID: 23433403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes.
    Davenport C; Ashley DT; O'Sullivan EP; McHenry CM; Agha A; Thompson CJ; O'Gorman DJ; Smith D
    J Diabetes Res; 2015; 2015():846807. PubMed ID: 26064990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Eur J Prev Cardiol; 2016 May; 23(7):744-7. PubMed ID: 26246463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term atorvastatin treatment decreases heart maximal oxygen consumption and its vulnerability to in vitro oxidative stress in Watanabe heritable hyperlipidemic rabbit.
    Tissier F; Farhat F; Philouze C; Desfontis JC; Didier R; Gilard M; Mallem MY; Mansourati J; Moisan C; Pichavant-Rafini K; Theron M; Amérand A
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1112-1118. PubMed ID: 30011375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of prolonged statin therapy on the arterial distensibility in stable ischemic heart disease].
    Kurpesa M; Tymiński M; Trzos E; Kidawa M; Krzemińska-Pakuła M
    Przegl Lek; 2005; 62(4):210-3. PubMed ID: 16229236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical Review on the Analytical Techniques for the Determination of the Oldest Statin-Atorvastatin-in Bulk, Pharmaceutical Formulations and Biological Fluids.
    Kokilambigai KS; Seetharaman R; Lakshmi KS
    Crit Rev Anal Chem; 2017 Nov; 47(6):538-555. PubMed ID: 28644038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
    Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity.
    Castejon R; Castañeda A; Sollet A; Mellor-Pita S; Tutor-Ureta P; Jimenez-Ortiz C; Yebra-Bango M
    Lupus; 2017 Apr; 26(4):355-364. PubMed ID: 27510602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus.
    Bank AJ; Wang H; Holte JE; Mullen K; Shammas R; Kubo SH
    Circulation; 1996 Dec; 94(12):3263-70. PubMed ID: 8989139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
    Shiomi M; Ito T
    Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical events within the arterial wall: The dynamic context for elastin fatigue.
    Hodis S; Zamir M
    J Biomech; 2009 May; 42(8):1010-6. PubMed ID: 19386312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in the static rheological properties of the aorta in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits with progress of atherosclerosis.
    Katsuda S; Machida N; Hasegawa M; Miyashita H; Kusanagi M; Tsubone H; Hazama A
    Physiol Meas; 2004 Apr; 25(2):505-22. PubMed ID: 15132315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of vascular smooth muscle, elastin and collagen on the passive mechanics of porcine carotid arteries.
    Kochová P; Kuncová J; Svíglerová J; Cimrman R; Miklíková M; Liška V; Tonar Z
    Physiol Meas; 2012 Aug; 33(8):1335-51. PubMed ID: 22813960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased IL-37 in Atherosclerotic Disease could be Suppressed by Atorvastatin Therapy.
    Shaoyuan C; Ming D; Yulang H; Hongcheng F
    Scand J Immunol; 2015 Oct; 82(4):328-36. PubMed ID: 26074195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
    Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
    Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.